These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 28403559)

  • 1. An Integrin-Targeting RGDK-Tagged Nanocarrier: Anticancer Efficacy of Loaded Curcumin.
    Das K; Nimushakavi S; Chaudhuri A; Das PK
    ChemMedChem; 2017 May; 12(10):738-750. PubMed ID: 28403559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Formulation of curcumin delivery with functionalized single-walled carbon nanotubes: characteristics and anticancer effects in vitro.
    Li H; Zhang N; Hao Y; Wang Y; Jia S; Zhang H; Zhang Y; Zhang Z
    Drug Deliv; 2014 Aug; 21(5):379-87. PubMed ID: 24160816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simultaneous delivery of doxorubicin and curcumin encapsulated in liposomes of pegylated RGDK-lipopeptide to tumor vasculature.
    Barui S; Saha S; Mondal G; Haseena S; Chaudhuri A
    Biomaterials; 2014 Feb; 35(5):1643-56. PubMed ID: 24239109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor growth inhibition through targeting liposomally bound curcumin to tumor vasculature.
    Mondal G; Barui S; Saha S; Chaudhuri A
    J Control Release; 2013 Dec; 172(3):832-40. PubMed ID: 24036260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Y-shaped Folic Acid-Conjugated PEG-PCL Copolymeric Micelles for Delivery of Curcumin.
    Feng R; Zhu W; Chu W; Teng F; Meng N; Deng P; Song Z
    Anticancer Agents Med Chem; 2017; 17(4):599-607. PubMed ID: 27528180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipopeptide with a RGDK tetrapeptide sequence can selectively target genes to proangiogenic alpha5beta1 integrin receptor and mouse tumor vasculature.
    Pramanik D; Majeti BK; Mondal G; Karmali PP; Sistla R; Ramprasad OG; Srinivas G; Pande G; Chaudhuri A
    J Med Chem; 2008 Nov; 51(22):7298-302. PubMed ID: 18956861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amphiphilic Peptide Nanorods Based on Oligo-Phenylalanine as a Biocompatible Drug Carrier.
    Song SJ; Lee S; Ryu KS; Choi JS
    Bioconjug Chem; 2017 Sep; 28(9):2266-2276. PubMed ID: 28742327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional single-walled carbon nanotubes based on an integrin alpha v beta 3 monoclonal antibody for highly efficient cancer cell targeting.
    Ou Z; Wu B; Xing D; Zhou F; Wang H; Tang Y
    Nanotechnology; 2009 Mar; 20(10):105102. PubMed ID: 19417509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergistic enhancement of cancer therapy using a combination of docetaxel and photothermal ablation induced by single-walled carbon nanotubes.
    Wang L; Zhang M; Zhang N; Shi J; Zhang H; Li M; Lu C; Zhang Z
    Int J Nanomedicine; 2011; 6():2641-52. PubMed ID: 22114495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comb-like amphiphilic copolymers bearing acetal-functionalized backbones with the ability of acid-triggered hydrophobic-to-hydrophilic transition as effective nanocarriers for intracellular release of curcumin.
    Zhao J; Wang H; Liu J; Deng L; Liu J; Dong A; Zhang J
    Biomacromolecules; 2013 Nov; 14(11):3973-84. PubMed ID: 24107101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Curcumin-containing liposomes stabilized by thin layers of chitosan derivatives.
    Karewicz A; Bielska D; Loboda A; Gzyl-Malcher B; Bednar J; Jozkowicz A; Dulak J; Nowakowska M
    Colloids Surf B Biointerfaces; 2013 Sep; 109():307-16. PubMed ID: 23668985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relative biomembrane fusogenicities of the tumor-selective liposomes of RGDK- and CGKRK-lipopeptides.
    Rahaman W; Chaudhuri A
    Nanoscale; 2024 May; 16(20):9836-9852. PubMed ID: 38713132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic Codelivery of a Homoserine Derived Ceramide Analogue and Curcumin to Tumor Vasculature Inhibits Mouse Tumor Growth.
    Barui S; Saha S; Yakati V; Chaudhuri A
    Mol Pharm; 2016 Feb; 13(2):404-19. PubMed ID: 26716471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physicochemical Characterization of Curcumin Loaded Chitosan Nanoparticles: Implications in Cervical Cancer.
    Khan MA; Zafaryab M; Mehdi SH; Ahmad I; Rizvi MMA
    Anticancer Agents Med Chem; 2018; 18(8):1131-1137. PubMed ID: 29651963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanostructured lipid carriers enhance the bioavailability and brain cancer inhibitory efficacy of curcumin both in vitro and in vivo.
    Chen Y; Pan L; Jiang M; Li D; Jin L
    Drug Deliv; 2016 May; 23(4):1383-92. PubMed ID: 26066035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced drug loading on magnetic nanoparticles by layer-by-layer assembly using drug conjugates: blood compatibility evaluation and targeted drug delivery in cancer cells.
    Manju S; Sreenivasan K
    Langmuir; 2011 Dec; 27(23):14489-96. PubMed ID: 21988497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis, and anticancer evaluation of long-chain alkoxylated mono-carbonyl analogues of curcumin.
    Weng Q; Fu L; Chen G; Hui J; Song J; Feng J; Shi D; Cai Y; Ji J; Liang G
    Eur J Med Chem; 2015 Oct; 103():44-55. PubMed ID: 26318057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Curcumin Delivery by Poly(Lactide)-Based Co-Polymeric Micelles: An In Vitro Anticancer Study.
    Kumari P; Swami MO; Nadipalli SK; Myneni S; Ghosh B; Biswas S
    Pharm Res; 2016 Apr; 33(4):826-41. PubMed ID: 26597940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mannich Curcuminoids as Potent Anticancer Agents.
    Gyuris M; Hackler L; Nagy LI; Alföldi R; Rédei E; Marton A; Vellai T; Faragó N; Ózsvári B; Hetényi A; Tóth GK; Sipos P; Kanizsai I; Puskás LG
    Arch Pharm (Weinheim); 2017 Jul; 350(7):. PubMed ID: 28547897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single subcutaneous administration of RGDK-lipopeptide:rhPDGF-B gene complex heals wounds in streptozotocin-induced diabetic rats.
    Bhattacharyya J; Mondal G; Madhusudana K; Agawane SB; Ramakrishna S; Gangireddy SR; Madhavi RD; Reddy PK; Konda VR; Rao SR; Udaykumar P; Chaudhuri A
    Mol Pharm; 2009; 6(3):918-27. PubMed ID: 19388683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.